Welcome to our dedicated page for Astronics SEC filings (Ticker: ATRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Astronics Corporation (NASDAQ: ATRO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered tools to help interpret them. As a supplier of advanced technologies and products to aerospace, defense and other mission-critical industries, Astronics uses its filings to report on segment performance, capital structure, risk factors and material agreements.
Investors can review current reports on Form 8-K that describe material events such as the entry into a new cash flow-based revolving credit facility, the termination of a prior asset-based credit agreement, and the issuance of 0% Convertible Senior Notes due 2031 paired with capped call transactions. These filings outline key terms, covenants, leverage and interest coverage ratios, and the use of proceeds for refinancing existing convertible notes and supporting general corporate purposes.
In addition to 8-Ks, Astronics’ annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via EDGAR) provide detail on the Aerospace and Test Systems segments, including how the company categorizes its markets, discloses research and development expense, and discusses bookings and backlog. Proxy materials and other filings offer further insight into governance and capital structure.
Stock Titan enhances access to these documents with AI-powered summaries that explain complex sections, highlight important terms in credit agreements and indentures, and clarify the implications of convertible note offerings and covenant packages. Users can also track insider transaction reports on Form 4 and other ownership-related filings to see how executives and significant holders are trading Astronics stock. Together, these tools help readers navigate Astronics’ regulatory record without manually parsing every page of each filing.
Linda O'Brien, a director of Astronics Corporation (ATRO), received 6,055 shares of common stock upon settlement of restricted stock units and increased her direct holdings to 19,839 shares. The filing shows 6,055 restricted stock units settled into shares at no cash price, and an additional 1,200 shares are reported as indirectly owned through her spouse. The transaction was reported on the Form 4 and executed under code M, with the shares added to her direct beneficial ownership.
This disclosure documents an insider equity settlement rather than an open-market purchase or sale, showing management compensation converted into common stock and clarifying both direct and spousal indirect ownership positions.
Jeffry D. Frisby, a director of Astronics Corporation (ATRO), received and settled restricted stock units into common stock on August 27, 2025. The filing shows Frisby was issued 6,055 restricted stock units that were settled for 6,055 shares of common stock at no cash price ($0 listed). After the transaction, Frisby beneficially owned 47,523 shares of Astronics common stock. The Form 4 was signed by a power of attorney on August 28, 2025.
Robert S. Keane, a director of Astronics Corporation (ATRO), reported transactions dated 08/27/2025 on a Form 4. He received 6,055 shares of common stock through the settlement of restricted stock units at no cash cost ($0 per share). After the settlement, Mr. Keane directly beneficially owned 12,401 shares of common stock.
The filing discloses material indirect holdings: 206,886 Class B shares (reported as indirect via Note 1) and 208,199 Class B shares (reported as indirect via Note 2). The filing explains these indirect interests arise from a trust and an LLC (Boston & Saranac LLC) that ultimately list Mr. Keane and his spouse as beneficiaries, with the reporting person’s proportionate interest below 25% of the trust.
Mark J. Moran, a director of Astronics Corp (ATRO), received 6,055 shares of common stock upon settlement of restricted stock units on 08/27/2025. The Form 4 shows these restricted stock units converted to common shares and recorded as an acquisition (transaction code M) with an indicated price of $0 and an ownership form marked Direct. After the settlement, Mr. Moran beneficially owned 42,523 shares. The filing was signed via power of attorney on 08/28/2025.
Robert T. Brady, a director of Astronics Corp (ATRO), reported transactions on August 27, 2025. The filing shows 6,055 restricted stock units were settled into 6,055 shares of common stock at no cash price. The report also lists dispositions of 85,069 common shares and 175,076 Class B shares (both shown as disposed). Brady retains several outstanding stock options and previously granted restricted units that were exercised or settled; option exercise prices and expiration dates are shown in the filing. The form was signed by a power of attorney on behalf of Brady.
Warren C. Johnson, a director of Astronics Corporation (ticker ATRO), reported transactions dated 08/27/2025. The filing discloses the settlement of 6,055 restricted stock units into shares of common stock on that date. The Form 4 lists existing derivative holdings consisting of stock options that convert into common and Class B shares: two option grants exercisable through 03/02/2028 and two exercisable through 03/07/2027 or 09/07/2027, covering 8,000 underlying common shares plus 1,200 underlying Class B shares in total. The report was signed by a power of attorney on 08/28/2025. The filing states the restricted stock units were settled for shares on the transaction date.
Astronics Corp director Fay West received 6,055 shares of common stock through the settlement of 6,055 restricted stock units on 08/27/2025. The Form 4 shows the restricted stock units were settled into shares and the reporting person beneficially owned 6,055 shares following the transaction. The filing was submitted by one reporting person and signed by Julie Davis as power of attorney on 08/28/2025. The transaction is recorded with a reported price of $0 (reflecting the RSU settlement) and is a routine equity award settlement by an insider.
Astronics Corp director Neil Y. Kim received 6,055 restricted stock units that were settled into common shares on 08/27/2025. The settlement increased his direct beneficial ownership to 42,523 shares. The Form 4 shows the RSUs were granted and settled as part of compensation (transaction code M) and recorded at a nominal price of $0 with a $0.01 par value reference. The filing also lists outstanding stock options exercisable through 2027 and 2028 with exercise prices of $28.50 and $34.04, and convertible/plan-designated shares tied to those options. The Form 4 was signed by a power of attorney on behalf of Mr. Kim on 08/28/2025.
Astronics Corporation is the subject of a Schedule 13G/A disclosing that The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report beneficial ownership of 223,444.91 shares of common stock, equal to 0.7% of the class. The cover-page details show 0 shares with sole voting or dispositive power and 223,429.91 shares with shared voting power and 223,444.91 with shared dispositive power.
The filing includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. An exhibit identifies Goldman Sachs & Co. LLC as a subsidiary of The Goldman Sachs Group and classifies the filers with broker-dealer and investment-adviser roles.
FAQ
What is the current stock price of Astronics (ATRO)?
What is the market cap of Astronics (ATRO)?
